Sognef Inc.
- UEI
- MUDPARQK9VL3
- CAGE
- 8PWL5
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- matterdx.com
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$299,856 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| R & d of sognef covid-19 test | Office of the Assistant Secretary for Preparedness and Response | $450,143 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Now Diagnostics | Springdale, AR | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Innotech Precision Medicine, Inc. | Boston, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Instadiagnostics Inc. | Philadelphia, PA | 339112 Surgical and Medical Instrument Manufacturing |
| Pathogendx Inc. | Tucson, AZ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| P B M | South Brunswick Township, NJ | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Sognef Inc. is a minority owned, self-certified small disadvantaged business registered to receive federal contract and grant awards. The company offers research and development services related to medical testing and biotechnology.
Sognef Inc. has received a prime federal contract award from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The $450,143 firm fixed price definitive contract was for the research and development of a low-cost, two-minute, saliva-based, polymerase chain reaction-grade, at-home COVID-19 test. The period of performance was from June 1, 2022 to September 12, 2023, with work to be performed in Alpharetta, Georgia. No set-aside was used for this contract award.
Sognef Inc. has also received federal grant sub-awards from The Johns Hopkins University. The sub-awards were for an "Exosome-based Non-traditional Technologies Towards Multi-Parametric and Untegrated Approaches for SARS-CoV-2" project, which likely involved research related to COVID-19 testing and diagnostics. However, no additional details are provided about the specific goods or services Sognef Inc. contributed under these sub-awards.
Quick answers
Is Sognef Inc. registered in SAM.gov?
Sognef Inc.'s SAM.gov registration expired on February 20, 2025.
What is Sognef Inc.'s most recent federal award?
Sognef Inc.'s most recent federal contract award is R & d of sognef covid-19 test (75A50122C00029), from Office of the Assistant Secretary for Preparedness and Response, on June 1, 2022.
On GovTribe
See Sognef Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors